Understanding lung cancer patient experiences with clinical trials
Part of Cancer, Lungs & breathing clinical trials.
This study looks at how people with non-small cell lung cancer experience the process of planning for and enrolling in clinical trials. It may help improve the way clinical trials are explained and supported for future patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with non-small cell lung cancer
- You are 18 years old or older
- You have said you plan to enroll in a non-small cell lung cancer clinical trial
- You can complete regular electronic (online) reporting
- You can understand and agree to participate (informed consent) and join the study without being blocked by a mental or medical condition
- You are not pregnant or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial does not test a new drug. It looks at existing medical records to compare how well different treatments work for people with advanced non-small cell lung cancer. You may be eligible if your cancer is advanced and you are not in another clinical trial.
This study looks at how tumor and blood biomarker results can guide treatment for people with non-small cell lung cancer (NSCLC). Depending on the cancer stage, it may follow standard-of-care treatment plans around surgery or first-line immunotherapy.
This study is looking at how non-small cell lung cancer (NSCLC) changes and progresses over time, from early to advanced stages. By studying people with all stages of the disease, researchers hope to learn more about what affects a person's prognosis and how the cancer evolves. This may help doctors better understand the cancer and develop better treatments.
This study looks at what doctors and patients consider when deciding on a first-line treatment for advanced lung cancer. It aims to understand how choices are made for people taking a type of targeted therapy.
This trial uses your tumor sample to guide personalized treatment decisions for certain lung cancers. It may help by matching you to a more targeted plan based on genetic testing and your prior treatment history.
This trial uses advanced gene sequencing technology on blood and tumor tissue samples from people with non-small cell lung cancer. The goal is to see if this testing can help doctors better predict which treatments will work and detect if the cancer comes back early.
Hear when a new Non Small Cell Lung Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.